Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 367

2.

Complications of Retroperitoneal Lymph Node Dissection.

Cary C, Foster RS, Masterson TA.

Urol Clin North Am. 2019 Aug;46(3):429-437. doi: 10.1016/j.ucl.2019.04.012. Review.

PMID:
31277737
3.

Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer.

Calaway AC, Einhorn LH, Masterson TA, Foster RS, Cary C.

Eur Urol. 2019 Nov;76(5):607-609. doi: 10.1016/j.eururo.2019.05.031. Epub 2019 Jun 4.

PMID:
31174891
4.

Oncologic Outcomes Following Surgical Management of Clinical Stage II Sex Cord Stromal Tumors.

Calaway AC, Tachibana I, Masterson TA, Foster RS, Einhorn LH, Cary C.

Urology. 2019 May;127:74-79. doi: 10.1016/j.urology.2019.02.014. Epub 2019 Feb 23.

PMID:
30807775
5.
6.

Risk of Bleomycin-Related Pulmonary Toxicities and Operative Morbidity After Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Good-Risk Germ Cell Tumors.

Calaway AC, Foster RS, Adra N, Masterson TA, Albany C, Hanna NH, Einhorn LH, Cary C.

J Clin Oncol. 2018 Oct 10;36(29):2950-2954. doi: 10.1200/JCO.18.00431. Epub 2018 Aug 29.

PMID:
30156983
7.

Management of patients with metastatic teratoma with malignant somatic transformation.

Speir R, Cary C, Foster RS, Masterson TA.

Curr Opin Urol. 2018 Sep;28(5):469-473. doi: 10.1097/MOU.0000000000000528. Review.

PMID:
29939859
8.

Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."

Thomas DE, Kaimakliotis HZ, Rice KR, Pereira JA, Johnston P, Moore ML, Reed A, Cregar DM, Franklin C, Loman RL, Koch MO, Bihrle R, Foster RS, Masterson TA, Gardner TA, Sundaram CP, Powell CR, Beck S, Grignon DJ, Cheng L, Albany C, Hahn NM.

Urol Oncol. 2018 Jul;36(7):345. doi: 10.1016/j.urolonc.2018.05.003. Epub 2018 Jun 5.

PMID:
29880459
9.

Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors.

Albany C, Adra N, Snavely AC, Cary C, Masterson TA, Foster RS, Kesler K, Ulbright TM, Cheng L, Chovanec M, Taza F, Ku K, Brames MJ, Hanna NH, Einhorn LH.

Ann Oncol. 2018 Feb 1;29(2):341-346. doi: 10.1093/annonc/mdx731.

10.

Long-Term Survival of Good-Risk Germ Cell Tumor Patients After Postchemotherapy Retroperitoneal Lymph Node Dissection: A Comparison of BEP × 3 vs. EP × 4 and Treating Institution.

Cary C, Jacob JM, Albany C, Masterson TA, Hanna NH, Einhorn LH, Foster RS.

Clin Genitourin Cancer. 2018 Apr;16(2):e307-e313. doi: 10.1016/j.clgc.2017.10.008. Epub 2017 Oct 16.

PMID:
29104087
11.

Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens.

Harari SE, Sassoon DJ, Priemer DS, Jacob JM, Eble JN, Caliò A, Grignon DJ, Idrees M, Albany C, Masterson TA, Hanna NH, Foster RS, Ulbright TM, Einhorn LH, Cheng L.

Urol Oncol. 2017 Oct;35(10):605.e9-605.e16. doi: 10.1016/j.urolonc.2017.05.018. Epub 2017 Jun 21. Review.

PMID:
28647396
12.

Preoperative Nomograms for Predicting Renal Function at 1 Year After Partial Nephrectomy.

Shum CF, Bahler CD, Cary C, Masterson TA, Boris RS, Gardner TA, Kaimakliotis HZ, Foster RS, Bihrle R, Koch MO, Slaven JE Jr, Sundaram CP.

J Endourol. 2017 Jul;31(7):711-718. doi: 10.1089/end.2017.0184.

PMID:
28443676
13.

Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant Chemotherapy.

Thomas DE, Kaimakliotis HZ, Rice KR, Pereira JA, Johnston P, Moore ML, Reed A, Cregar DM, Franklin C, Loman RL, Koch MO, Bihrle R, Foster RS, Masterson TA, Gardner TA, Sundaram CP, Powell CR, Beck SDW, Grignon DJ, Cheng L, Albany C, Hahn NM.

Clin Genitourin Cancer. 2017 Aug;15(4):479-486. doi: 10.1016/j.clgc.2016.11.009. Epub 2016 Nov 30.

14.

A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with FGFR3 Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157.

Hahn NM, Bivalacqua TJ, Ross AE, Netto GJ, Baras A, Park JC, Chapman C, Masterson TA, Koch MO, Bihrle R, Foster RS, Gardner TA, Cheng L, Jones DR, McElyea K, Sandusky GE, Breen T, Liu Z, Albany C, Moore ML, Loman RL, Reed A, Turner SA, De Abreu FB, Gallagher T, Tsongalis GJ, Plimack ER, Greenberg RE, Geynisman DM.

Clin Cancer Res. 2017 Jun 15;23(12):3003-3011. doi: 10.1158/1078-0432.CCR-16-2267. Epub 2016 Dec 8.

15.

Management of Pelvic Metastases in Patients With Testicular Cancer.

Jacob JM, Mehan R, Beck SD, Cary C, Masterson TA, Bihrle R, Foster RS.

Urology. 2017 Apr;102:159-163. doi: 10.1016/j.urology.2016.08.063. Epub 2016 Nov 10.

PMID:
27840253
16.

Author Reply.

Jacob JM, Cary C, Foster RS, House MG.

Urology. 2017 Jan;99:173. doi: 10.1016/j.urology.2016.04.063. Epub 2016 Nov 7. No abstract available.

PMID:
27829529
17.

Management of Duodenal Involvement During Retroperitoneal Lymph Node Dissection for Germ Cell Tumors.

Jacob JM, Cary C, Jiang S, Foster RS, House MG.

Urology. 2017 Jan;99:169-173. doi: 10.1016/j.urology.2016.04.061. Epub 2016 Sep 19.

PMID:
27658663
18.

Granular parakeratosis induced by benzalkonium chloride exposure from laundry rinse aids.

Robinson AJ, Foster RS, Halbert AR, King E, Orchard D.

Australas J Dermatol. 2017 Aug;58(3):e138-e140. doi: 10.1111/ajd.12551. Epub 2016 Sep 19.

PMID:
27641714
19.

Neoadjuvant chemotherapy in urothelial bladder cancer: impact of regimen and variant histology.

Kaimakliotis HZ, Monn MF, Cho JS, Pedrosa JA, Hahn NM, Albany C, Gellhaus PT, Cary KC, Masterson TA, Foster RS, Bihrle R, Cheng L, Koch MO.

Future Oncol. 2016 Aug;12(15):1795-804. doi: 10.2217/fon-2016-0056. Epub 2016 Jun 3.

PMID:
27255805
20.

Reply.

Sharma A, Smith D, Kraft SP, Ali A, Foster RS, Suh DW.

Am J Ophthalmol. 2016 Apr;164:147. doi: 10.1016/j.ajo.2016.02.006. Epub 2016 Mar 2. No abstract available.

PMID:
26944754
21.

Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration.

Giannatempo P, Pond GR, Sonpavde G, Albany C, Loriot Y, Sweeney CJ, Salvioni R, Colecchia M, Nicolai N, Raggi D, Rice KR, Flack CK, El Mouallem NR, Feldman H, Fizazi K, Einhorn LH, Foster RS, Necchi A, Cary C.

J Urol. 2016 Jul;196(1):95-100. doi: 10.1016/j.juro.2015.12.082. Epub 2015 Dec 31.

PMID:
26748165
22.

Idiopathic Enlargement of the Extraocular Muscles in Young Patients: A Case Series.

Sharma A, Foster RS, Suh DW, Smith D, Kraft SP, Ali A.

Am J Ophthalmol. 2016 Jan;161:206-13. doi: 10.1016/j.ajo.2015.10.019. Epub 2015 Nov 14.

PMID:
26521716
23.

Outcomes of postchemotherapy retroperitoneal lymph node dissection following high-dose chemotherapy with stem cell transplantation.

Cary C, Pedrosa JA, Jacob J, Beck SD, Rice KR, Einhorn LH, Foster RS.

Cancer. 2015 Dec 15;121(24):4369-75. doi: 10.1002/cncr.29678. Epub 2015 Sep 15.

24.

Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity.

Hahn NM, Knudsen BS, Daneshmand S, Koch MO, Bihrle R, Foster RS, Gardner TA, Cheng L, Liu Z, Breen T, Fleming MT, Lance R, Corless CL, Alva AS, Shen SS, Huang F, Gertych A, Gallick GE, Mallick J, Ryan C, Galsky MD, Lerner SP, Posadas EM, Sonpavde G.

Urol Oncol. 2016 Jan;34(1):4.e11-7. doi: 10.1016/j.urolonc.2015.08.005. Epub 2015 Sep 9.

PMID:
26362343
25.

Risk for Clostridium difficile infection after radical cystectomy for bladder cancer: Analysis of a contemporary series.

Liu NW, Shatagopam K, Monn MF, Kaimakliotis HZ, Cary C, Boris RS, Mellon MJ, Masterson TA, Foster RS, Gardner TA, Bihrle R, House MG, Koch MO.

Urol Oncol. 2015 Dec;33(12):503.e17-22. doi: 10.1016/j.urolonc.2015.07.007. Epub 2015 Aug 14.

26.

Risk of Recurrence for Clinical Stage I and II Patients With Teratoma Only at Primary Retroperitoneal Lymph Node Dissection.

Liu NW, Cary C, Strine AC, Beck SD, Masterson TA, Bihrle R, Foster RS.

Urology. 2015 Nov;86(5):981-4. doi: 10.1016/j.urology.2015.06.004. Epub 2015 Jul 29.

PMID:
26232690
27.

The Evolution and Technique of Nerve-Sparing Retroperitoneal Lymphadenectomy.

Masterson TA, Cary C, Rice KR, Foster RS.

Urol Clin North Am. 2015 Aug;42(3):311-20. doi: 10.1016/j.ucl.2015.04.005. Epub 2015 Jun 6. Review.

PMID:
26216818
28.

Differentiating reconstructive techniques in partial nephrectomy: a propensity score analysis.

Bahler CD, Cary KC, Garg S, DeRoo EM, Tabib CH, Kansal JK, Monn MF, Flack CK, Masterson TA, Sandrasegaran MK, Foster RS, Sundaram CP.

Can J Urol. 2015 Jun;22(3):7788-96.

PMID:
26068626
29.

Three-tiered nodal classification system for bladder cancer: a new proposal.

Pedrosa JA, Koch MO, Kaimakliotis HZ, Monn MF, Masterson TA, Rice KR, Cary KC, Foster RS, Bihrle R, Cheng L.

Future Oncol. 2015;11(3):399-408. doi: 10.2217/fon.14.267.

PMID:
25675122
30.

Feasibility of omitting cortical renorrhaphy during robot-assisted partial nephrectomy: a matched analysis.

Bahler CD, Dube HT, Flynn KJ, Garg S, Monn MF, Gutwein LG, Mellon MJ, Foster RS, Cheng L, Sandrasegaran MK, Sundaram CP.

J Endourol. 2015 May;29(5):548-55. doi: 10.1089/end.2014.0763. Epub 2015 Mar 10.

PMID:
25616087
31.

Contemporary trends in postchemotherapy retroperitoneal lymph node dissection: Additional procedures and perioperative complications.

Cary C, Masterson TA, Bihrle R, Foster RS.

Urol Oncol. 2015 Sep;33(9):389.e15-21. doi: 10.1016/j.urolonc.2014.07.013. Epub 2015 Jan 5.

PMID:
25573056
32.

Cu-promoted sydnone cycloadditions of alkynes: scope and mechanism studies.

Comas-Barceló J, Foster RS, Fiser B, Gomez-Bengoa E, Harrity JP.

Chemistry. 2015 Feb 16;21(8):3257-63. doi: 10.1002/chem.201406118. Epub 2014 Dec 30.

33.

Surgical management of late relapse on surveillance in patients presenting with clinical stage I testicular cancer.

Rice KR, Beck SD, Pedrosa JA, Masterson TA, Einhorn LH, Foster RS.

Urology. 2014 Oct;84(4):886-90. doi: 10.1016/j.urology.2014.05.054.

PMID:
25260450
34.

The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.

Cary KC, Pedrosa JA, Kaimakliotis HZ, Masterson TA, Einhorn LH, Foster RS.

J Urol. 2015 Feb;193(2):507-12. doi: 10.1016/j.juro.2014.09.090. Epub 2014 Sep 22.

PMID:
25254937
35.

Acute onset of pustules at the site of tape placement in an immunocompromised infant with acute myeloid leukemia. Diagnosis: primary cutaneous aspergillosis.

Anderson A, Foster RS, Brand R, Blyth CC, Kotecha RS.

Pediatr Dermatol. 2014 Sep-Oct;31(5):609-10. doi: 10.1111/pde.12343. No abstract available.

PMID:
25187388
36.

The changing reality of urothelial bladder cancer: should non-squamous variant histology be managed as a distinct clinical entity?

Monn MF, Kaimakliotis HZ, Cary KC, Bihrle R, Pedrosa JA, Masterson TA, Foster RS, Gardner TA, Cheng L, Koch MO.

BJU Int. 2015 Aug;116(2):236-40. doi: 10.1111/bju.12877. Epub 2015 Mar 6.

37.

Critical analysis of the 2010 TNM classification in patients with lymph node-positive bladder cancer: influence of lymph node disease burden.

Pedrosa JA, Kaimakliotis HZ, Monn MF, Cary KC, Masterson TA, Rice KR, Foster RS, Bihrle R, Koch MO, Cheng L.

Urol Oncol. 2014 Oct;32(7):1003-9. doi: 10.1016/j.urolonc.2014.04.002. Epub 2014 Jul 11.

PMID:
25027685
38.

Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?

Kaimakliotis HZ, Monn MF, Cary KC, Pedrosa JA, Rice K, Masterson TA, Gardner TA, Hahn NM, Foster RS, Bihrle R, Cheng L, Koch MO.

Urol Oncol. 2014 Aug;32(6):833-8. doi: 10.1016/j.urolonc.2014.03.008. Epub 2014 Jun 18.

PMID:
24954925
39.

Management of germ cell tumors with somatic type malignancy: pathological features, prognostic factors and survival outcomes.

Rice KR, Magers MJ, Beck SD, Cary KC, Einhorn LH, Ulbright TM, Foster RS.

J Urol. 2014 Nov;192(5):1403-9. doi: 10.1016/j.juro.2014.05.118. Epub 2014 Jun 18.

PMID:
24952240
40.

"Somatic-type" malignancies arising from testicular germ cell tumors: a clinicopathologic study of 124 cases with emphasis on glandular tumors supporting frequent yolk sac tumor origin.

Magers MJ, Kao CS, Cole CD, Rice KR, Foster RS, Einhorn LH, Ulbright TM.

Am J Surg Pathol. 2014 Oct;38(10):1396-409. doi: 10.1097/PAS.0000000000000262.

PMID:
24921638
41.

Survival analysis of pure seminoma at post-chemotherapy retroperitoneal lymph node dissection.

Rice KR, Beck SD, Bihrle R, Cary KC, Einhorn LH, Foster RS.

J Urol. 2014 Nov;192(5):1397-402. doi: 10.1016/j.juro.2014.04.097. Epub 2014 May 9.

PMID:
24813309
42.

Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes.

Kaimakliotis HZ, Monn MF, Cheng L, Masterson TA, Cary KC, Pedrosa JA, Foster RS, Koch MO, Bihrle R.

Urology. 2014 May;83(5):1112-6. doi: 10.1016/j.urology.2013.12.035. Epub 2014 Feb 26.

PMID:
24582117
43.

Reoperative retroperitoneal lymph node dissection for metastatic germ cell tumors: analysis of local recurrence and predictors of survival.

Pedrosa JA, Masterson TA, Rice KR, Bihrle R, Beck SD, Foster RS.

J Urol. 2014 Jun;191(6):1777-82. doi: 10.1016/j.juro.2014.01.010. Epub 2014 Feb 8.

PMID:
24518787
44.

What are the indications for postchemotherapy retroperitoneal lymph node dissection?

Einhorn LH, Foster RS.

Ann Oncol. 2014 Feb;25(2):301-3. doi: 10.1093/annonc/mdt493. Epub 2014 Jan 3. No abstract available.

PMID:
24389117
45.

Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: follow up of a pilot study and promising future directions.

Tu J, Foster RS, Bint LJ, Halbert AR.

Australas J Dermatol. 2014 Feb;55(1):63-9. doi: 10.1111/ajd.12125. Epub 2013 Dec 22.

PMID:
24359523
46.

Synthesis of 4-fluoromethylsydnones and their participation in alkyne cycloaddition reactions.

Foster RS, Adams H, Jakobi H, Harrity JP.

J Org Chem. 2013 Apr 19;78(8):4049-64. doi: 10.1021/jo400381a. Epub 2013 Apr 10.

PMID:
23548035
47.

Incidence, histology and management of intraluminal thrombus at post-chemotherapy retroperitoneal lymph node dissection.

Johnston P, Beck SD, Cheng L, Masterson TA, Bihrle R, Kesler K, Foster RS.

J Urol. 2013 Sep;190(3):874-7. doi: 10.1016/j.juro.2013.03.039. Epub 2013 Mar 19.

PMID:
23517745
48.

Molecular genetic evidence supporting the origin of somatic-type malignancy and teratoma from the same progenitor cell.

Kum JB, Ulbright TM, Williamson SR, Wang M, Zhang S, Foster RS, Grignon DJ, Eble JN, Beck SD, Cheng L.

Am J Surg Pathol. 2012 Dec;36(12):1849-56. doi: 10.1097/PAS.0b013e31826df1ab.

PMID:
23154771
49.

Clinical and pathological features predictive of nephrectomy at post-chemotherapy retroperitoneal lymph node dissection.

Cary KC, Beck SD, Bihrle R, Foster RS.

J Urol. 2013 Mar;189(3):812-7. doi: 10.1016/j.juro.2012.09.083. Epub 2012 Sep 24.

PMID:
23017517
50.

A general and regioselective synthesis of 5-trifluoromethyl-pyrazoles.

Foster RS, Jakobi H, Harrity JP.

Org Lett. 2012 Sep 21;14(18):4858-61. Epub 2012 Aug 30.

PMID:
22934538

Supplemental Content

Loading ...
Support Center